Top Markets
Coin of the day
In Veritas Medical Diagnostics, Inc. In Veritas Medical Diagnostics, Inc.

In Veritas Medical Diagnostics, Inc.

IVME
주식 순위 #41113
In Veritas Medical Diagnostics, Inc. (IVME) is a company currently in its... In Veritas Medical Diagnostics, Inc. (IVME) is a company currently in its development phase, dedicated to researching and creating advanced medical devices for point-of-care diagnostics. Their leading product is a prothrombin monitor, which assesses blood coagulation in patients at risk of cardiovascular diseases and strokes. The company is also actively developing an array of other diagnostic tools. These include a consumer-oriented device to predict the onset of labor for maternity planning, a comprehensive biomarker monitor capable of identifying indicators for conditions such as heart attacks, HIV, cholesterol levels, and cancer. Further innovations under development feature a non-invasive device for continuous blood glucose concentration measurement, a digital scanning machine designed as a non-invasive alternative to traditional 2D X-rays, and an osteoporosis device providing instant bone mineral density readings for patients. Additionally, they are working on a portable digital strip reader for immunoassay applications. Formerly known as In Vivo Medical Diagnostics, Inc., the company officially adopted its current name in 2005. Its operations are headquartered in Inverness, United Kingdom.
주가
$0.0007
마지막 동기화: 2025-09-02
시가총액
$42.26K
변동 (1일)
0.00%
변동 (1년)
0.00%
국가
GB
거래 In Veritas Medical Diagnostics, Inc. (IVME)
In Veritas Medical Diagnostics, Inc. (IVME)의 P/S 비율
2026 기준 P/S 비율 TTM: 0
In Veritas Medical Diagnostics, Inc.의 최신 재무 보고서와 주가에 따르면 현재 P/S 비율(TTM)은 0입니다. 2026년 말 기준 P/S 비율은 0였습니다.
In Veritas Medical Diagnostics, Inc.의 P/S 비율 기록 (2026 ~ 2026)
매년 말 P/S 비율
연도 P/S 비율 변화
제공된 날짜에 대한 데이터가 충분하지 않습니다.
유사 기업 또는 경쟁사의 P/S 비율